Literature DB >> 1334263

A simple method for elimination of unspecific amplifications in polymerase chain reaction.

J K Sharma1, V Gopalkrishna, B C Das.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1334263      PMCID： PMC334491          DOI： 10.1093/nar/20.22.6117

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  4 in total

1.  Looking for human papillomavirus type 16 by PCR.

Authors:  M Manos; K Lee; C Greer; J Waldman; N Kiviat; K Holmes; C Wheeler
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

2.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

3.  Uric acid as an inhibitor of cyclophosphamide-induced micronuclei in mice.

Authors:  A M al-Bekairi; S Qureshi; M A Chaudhry; A H Shah
Journal:  Mutat Res       Date:  1991-02       Impact factor: 2.433

Review 4.  Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers.

Authors:  H zur Hausen
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701
  4 in total
  10 in total

1.  Contamination and sensitivity issues with a real-time universal 16S rRNA PCR.

Authors:  C E Corless; M Guiver; R Borrow; V Edwards-Jones; E B Kaczmarski; A J Fox
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

2.  DNase pretreatment of master mix reagents improves the validity of universal 16S rRNA gene PCR results.

Authors:  Alexandra Heininger; Marlies Binder; Andreas Ellinger; Konrad Botzenhart; Klaus Unertl; Gerd Döring
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting.

Authors:  Tim Schuurman; Richard F de Boer; Anna M D Kooistra-Smid; Anton A van Zwet
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

4.  Comparison of different decontamination methods for reagents to detect low concentrations of bacterial 16S DNA by real-time-PCR.

Authors:  Sven Klaschik; Lutz E Lehmann; Ansgar Raadts; Andreas Hoeft; Frank Stuber
Journal:  Mol Biotechnol       Date:  2002-11       Impact factor: 2.695

5.  Presence of bacterial phage-like DNA sequences in commercial Taq DNA polymerase reagents.

Authors:  Tamara Newsome; Bing-Jie Li; Nianxiang Zou; Shyh-Ching Lo
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

6.  Enhancement of PCR Detection Limit by Single-Tube Restriction Endonuclease-PCR (RE-PCR).

Authors:  Sibnarayan Datta; Raghvendra Budhauliya; Soumya Chatterjee; Vijay Veer; Runu Chakravarty
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

7.  Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction.

Authors:  V Gopalkrishna; U R Singh; P Sodhani; J K Sharma; S T Hedau; A K Mandal; B C Das
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Detection of human papillomavirus DNA sequences in cancer of the urinary bladder by in situ hybridisation and polymerase chain reaction.

Authors:  V Gopalkrishna; A N Srivastava; S Hedau; J K Sharma; B C Das
Journal:  Genitourin Med       Date:  1995-08

9.  Optimizing Taq polymerase concentration for improved signal-to-noise in the broad range detection of low abundance bacteria.

Authors:  Rudolph Spangler; Noel L Goddard; David S Thaler
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

10.  Influence of long time storage in mineral water on RNA stability of Pseudomonas aeruginosa and Escherichia coli after heat inactivation.

Authors:  Claire Cenciarini; Sophie Courtois; Didier Raoult; Bernard La Scola
Journal:  PLoS One       Date:  2008-10-20       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.